吉林省集安益盛药业股份有限公司第九届董事会第五次会议决议公告

Core Viewpoint - The company, Jilin Province Jichang Yisheng Pharmaceutical Co., Ltd., has approved the use of idle self-owned funds to purchase financial products to enhance fund utilization efficiency and increase returns while ensuring operational needs and fund safety [4][10]. Group 1: Meeting Details - The ninth board meeting was held on February 4, 2026, with all nine directors present, and the meeting was deemed legal and effective [1]. - The board unanimously approved the proposal to use idle self-owned funds for purchasing financial products with a vote of 9 in favor, 0 against, and 0 abstentions [1]. Group 2: Investment Proposal - The company plans to use no more than 50 million RMB of idle self-owned funds for purchasing financial products, with a maximum investment period of 12 months [4][5]. - The investment aims to improve fund utilization efficiency and increase company returns without affecting normal business operations [4][10]. Group 3: Investment Guidelines - The company will invest in financial products issued by banks, securities firms, and asset management companies, focusing on high safety and good liquidity [6]. - The financial director is authorized to sign relevant contracts within the approved limit, and the finance department will oversee the implementation [6][7]. Group 4: Impact on Operations - The funds used for purchasing financial products will be limited to idle self-owned funds, ensuring that daily operational needs and fund safety are prioritized [10]. - This investment strategy is expected to enhance fund efficiency and yield, contributing positively to the company's overall performance and shareholder interests [10].

YISHENG PHARM-吉林省集安益盛药业股份有限公司第九届董事会第五次会议决议公告 - Reportify